An Overview of a New Approach in Evaluation, Verification and Validity of in Vitro Diagnosis (IVDs) Performance in Iran

By Samiee, Siamak Mirab; Farzami, Marjan Rahnomaye et al. | Iranian Journal of Public Health, January 2013 | Go to article overview

An Overview of a New Approach in Evaluation, Verification and Validity of in Vitro Diagnosis (IVDs) Performance in Iran


Samiee, Siamak Mirab, Farzami, Marjan Rahnomaye, Aliasgharpour, Mehri, Rafie, Mehdi, Entekhabie, Beata, Sabzavie, Fariba, Iranian Journal of Public Health


Dear Editor-in-Chief

According to many questions arising in clinical laboratories community on quality assessment and performance of In Vitro Diagnosis (IVDs) process in Iran, we are publishing a descriptive detailed process of Ministry of Health & Medical Education (MHME) role in achieving a permit for importing or local production of IVDs, supervi-sions on distribution, consumption, post market-ing monitoring, limitations, and future prospects of Reference Health Laboratory (RHL) and its role in improving each step.

The quality assessment & performance of IVDs program, is among other important quality assur-ance issues in medical laboratories of Iran started at RHL of MHME many years ago. At that time the results of a data set produced by RHL was the base for introducing and choosing of a product in the market. However, in recent years, issues such as introducing different technologies, competition of companies (local manufactures /importers), variety in clinical assessment analysis along with significant technical performance differences among IVDs in conducted analytical and clinical studies, and also different relevant certificates and approvals in a product technical file, have caused the clinical laboratories & technology manage-ment office to breakdown the evaluation process and consider other effective parameters to im- prove the investigation steps. These processes which at present are being proceeded in Medical Equipment office (MEO) with RHL cooperation for reviewing the technical file and performance evaluation are as follows (1-3):

1- A company Registration

All legal & real people according to law may act in manufacturing, and in IVDs importing. The necessary steps are:

* Introduce themselves to MEO and present a sample of the company's stamp with neces-sary documents indicating authorization of them.

* Fill out necessary application forms.

* Pass the training courses with at least mini-mum acceptable score.

* Receive an activity I.D from MEO after pre-senting all necessary documents and permits.

2- IVD Registration

The applicant at this step presents an appropriate request for reviewing the IVD/s technical file to MEO. The technical file should be in special for-mat and contain(2,3) the following items:

* Executive Summary

* Device Description

* Design Philosophy

* Marketing History

* Standards Lists

* Performance Evaluation Documents

* Common Technical Specifications (CTS)

* Risk Management

* Labeling

* Quality Management System (ISO 13485)

* International Certificates: FDA, CE or CE Declaration of Conformity (whether or not).

Each of the above sections reveals important information on a product quality and performance specifications. For example, marketing history has a valuable impact indicating the product has al-ready been distributed in regulated international markets. Furthermore, if validity of international certificates is suspected, it is clarified through communication with issuing agencies.

The responsibility of RHL, as mentioned earlier, is reviewing the technical file of products in details by its expert technologist, and performance evaluation in cases that is needed. If the gathered data are complete and adequate, they are pre-sented at "Registry Committee" and the final re-sult is then reported to MEO.

The members of IVDs Registry Committee, held 2-3x monthly at RHL, are RHL general director and representatives from two offices as fixed members. In addition, experts from other related organs may be invited to attend the relevant ses-sions of the committee. The final decision of committee is categorized in four different groups:

* To evaluate a product technically at RHL or other collaborating laboratories based on RHL protocol.

* To receive an import permit for a limited number of products after necessary quality and IVDs performance evaluation in collaborating laboratories at specific time period determined by RHL. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

An Overview of a New Approach in Evaluation, Verification and Validity of in Vitro Diagnosis (IVDs) Performance in Iran
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.